MF7 Ventures
Miami- based, early venture capital fund focused on emerging healthcare technologies delivering improved patient outcomes and cost savings to the supporting health system.
Founded in the of Fall of 2014, the fund has deployed capital in specific areas of the healthcare industry including prescription digital therapeutics, early disease detection platforms and technologies that enable precision and personalized medicine.
MF7 Ventures selects and invests in disruptive and innovative technologies with exceptionally talented management teams, working on large unmet medical needs, poised to deliver strong growth, scalable business models and attractive investor returns.
New portfolio companies must have clinical validation data to support the application of their technology as well as seasoned management teams with strong track record and proven financial discipline to build long term successful companies.
Our team works closely with purposeful Founders and Entrepreneurs driven by a mission to develop products and technologies that improve patient outcomes while managing health costs and making a big impact on human health.
MF7 Ventures gets involved in all aspects of entrepreneurship from bringing venture capital from our investor network, supporting operational execution and strategic guidance through our advisory services business and access to our industry network to drive meaningful business partnerships for our portfolio companies.
Current Portfolio: Click Therapeutics, Phenomics Health, Biograph55, MeCo Diagnostics, and VisionGate
Who We Are
MF7 Ventures is a Miami- based, early venture capital fund focused on emerging healthcare technologies delivering improved patient outcomes and cost savings to the supporting health system.
Founded in the of Fall of 2014, the fund has deployed capital in specific areas of the healthcare industry including prescription digital therapeutics, early disease detection platforms and technologies that enable precision and personalized medicine.
What We Do
MF7 Ventures selects and invests in disruptive and innovative technologies with exceptionally talented management teams, working on large unmet medical needs, poised to deliver strong growth, scalable business models and attractive investor returns.
New portfolio companies must have clinical validation data to support the application of their technology as well as seasoned management teams with strong track record and proven financial discipline to build long term successful companies.
How We Differ
MF7 Ventures differs from other funds in that, not only we invest in our portfolio companies, but we also bring our strategic and operational expertise to the table to advice and support the management of our portfolio investments and to accelerate their growth plans.
We specialize in three specific areas of the healthcare industry including prescription digital therapeutics, early disease detection platforms and technologies that enable precision and personalized medicine.
Maria Forero
Founding Partner
Maria brings over 25-years of experience in the healthcare sector, working alongside companies of all sizes and assisting them across an entire spectrum of functions, including: Strategic Planning, Financing, Business Development, Partnership Management, Sales and Marketing, and Capital Raising. Maria is originally a Human Geneticist by training, turned Accountant, Investment Banker, Venture Investor and Healthcare Executive. She has extensive international operational experience across different continents.
Since July 2022, Maria has been a senior Investment Director and Head of Operations and Marketing at Accelmed, a $400M Private Equity Fund in Miami focused on acquiring and investing in US commercial-stage Health Tech companies. Prior to that, Maria founded and is currently Managing Partner of MF7 Ventures Fund, a Miami-based, early seed venture fund focused on Digital Health, Precision Medicine and Early Cancer Detection Technologies.
Before becoming a venture investor, Maria spent 10 years at a Swiss Pharma company, called Novartis, in many senior roles. She is the former Head of Sales & Marketing for Sandoz Latin America and former CEO/GM of Spain & Portugal at Novartis Vaccines & Diagnostics. Prior to this, Maria worked in investment banking as former Vice President of Healthcare at Morgan Stanley, London. She trained as a certified accountant and audit manager at PricewaterhouseCoopers, London. She holds an MPH from Columbia University, New York and a BSc in Human Genetics, from the University College London.
She is the mother of an eight-year-old boy named Lukas and enjoys many hobbies (marathon running, ashtanga yoga, tennis, paddle boarding and classical guitar)
Our Strategy
MF7 Ventures selects and invests in disruptive and innovative technologies with exceptionally talented management teams, working on large unmet medical needs, poised to deliver strong growth, scalable business models and attractive investor returns.
New portfolio companies must have clinical validation data to support the application of their technology as well as seasoned management teams with strong track record and proven financial discipline to build long term successful companies.
